Details for 2016758337

Up to date per 02.04.2026

Actions

Title / Product Name

ARZNEIMITTELKOMBINATION ENTHALTEND LIPOSOMALES IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL UND LEUCOVORIN ZUR BEHANDLUNG VON METASTASIERENDEM PANKREASKREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016758337

EP Publication Number

3337478

E-Number

1300845

Language

PCT Number

US16047727

Publication Date

27.06.2018 A

12.08.2020 B1

Registration Date

12.08.2020

AT Publication Date

15.09.2020

Application Date

19.08.2016

Registration Number

Priorities

21.08.2015

201562208209 P

10.09.2015

201562216736 P

30.12.2015

201562273244 P

21.01.2016

201662281473 P

02.03.2016

201662302341 P

15.04.2016

201662323245 P

31.05.2016

201662343313 P

IPC

A61K 31/436 20060101AFI20170316BHEP

Maximum Duration of Protection

19.08.2036

Owner

Ipsen Biopharm Ltd.Ash Road Wrexham Industrial Estate Wrexham LL13 9UFGB

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

BLANCHETTE, Sarah, F.24 Edgemere Road Lynnfield, MA 01940US

FITZGERALD, Jonathan, Basil32 Magnolia Street Arlington, MA 02474US

GADDY, Daniel, F.250 Kendall Street Cambridge, MA 02141US

HENDRIKS, Bart, S.225 Cross Street Belmont, MA 02478US

KALRA, Ashish19 Burnham Street Unit D2 Belmont, MA 02478US

LEE, Helen120 Rindge Avneue Apt. 100 Cambridge, MA 02140US

BAYEVER, Eliel225 West 60th Street PH1D New York, NY 10023US

Information about Fees